Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 93.5 pp 528-537
DOI: 10.1113/expphysiol.2007.040345
© The Physiological Society 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/5/528    most recent
expphysiol.2007.040345v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alenina, N.
Right arrow Articles by Bader, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alenina, N.
Right arrow Articles by Bader, M.
Related Collections
Right arrow Review Articles
Right arrow Vascular

Review Articles

Genetically altered animal models for Mas and angiotensin-(1–7)

Natalia Alenina1, Ping Xu1, Brit Rentzsch1, Eugene L. Patkin2 and Michael Bader1

1 Max-Delbrück-Center for Molecular Medicine (MDC), D-13092 Berlin-Buch, Germany 2 Institute for Experimental Medicine, Russian Academy of Medical Sciences, St Petersburg, Russia

Mas is the receptor for angiotensin-(1–7) and is involved in cardiovascular and neuronal regulation, in which the heptapeptide also plays a major role. Mas-deficient mice have been generated by us, and their characterization has shown that Mas has important functions in behaviour and cardiovascular regulation. These mice exhibit increased anxiety but, despite an enhanced long-term potentiation in the hippocampus, do not perform better in learning experiments. When Mas-deficient mice are backcrossed to the FVB/N genetic background, a cardiovascular phenotype is uncovered, in that the backcrossed animals become hypertensive. Concordant with our detection by fluorescent in situ hybridization of Mas mRNA in mouse endothelium, this phenotype is caused by endothelial dysfunction based on a dysbalance between nitric oxide and reactive oxygen species in the vessel wall. In agreement with these data, transgenic spontaneously hypertensive stroke-prone rats overexpressing ACE2 in the vessel wall exhibit reduced blood pressure as a result of improved endothelial function. Moreover, angiotensin-(1–7) overexpression in transgenic rats has cardioprotective and haemodynamic effects. In conclusion, the angiotensin-(1–7)–Mas axis has important functional implications for vascular regulation and blood pressure control, particularly in pathophysiological situations.

(Received 15 November 2007; accepted after revision 17 December 2007; first published online 21 December 2007)
Corresponding author M. Bader: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Strasse 10, D-13092 Berlin-Buch, Germany. Email: mbader{at}mdc-berlin.de







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the The Physiological Society.